CSB530 Pharmacotherapeutics for Podiatrists
To view more information for this unit, select Unit Outline from the list below. Please note the teaching period for which the Unit Outline is relevant.
| Unit code: | CSB530 |
|---|---|
| Prerequisite(s): | LSB384 or PUB437 or CSB601 |
| Equivalent(s): | LSB584 |
| Credit points: | 12 |
| Timetable | Details in HiQ, if available |
| Availabilities |
|
| CSP student contribution | $1,037 |
| Domestic tuition unit fee | $4,032 |
| International unit fee | $4,392 |
Unit Outline: Semester 1 2023, Gardens Point, Internal
| Unit code: | CSB530 |
|---|---|
| Credit points: | 12 |
| Pre-requisite: | PUB437 or CSB601 |
| Coordinator: | Andrew Hale | a3.hale@qut.edu.au |
Overview
This unit will extend your knowledge of the pharmacology and the therapeutic use of the medicines administered and prescribed for the treatment of the disease states encountered in the scope of your professional podiatry practice in Australia. Selection of drugs and discussion of their therapeutic use by Podiatrists is based on the Clinical Practice Guidelines of the Podiatry Board of Australia, particularly Appendix B: List of Scheduled Medicines Approved by the Podiatry Board of Australia. Additionally, you will be introduced to resources available in Australia guiding you towards the appropriate selection and use of these medicines, including clinical trials and recognised clinical guidelines e.g. the Therapeutic Guidelines, Australian Medicines Handbook (AMH), Monthly Index of Medical Specialties better known as MIMS, Therapeutic Goods Administration (TGA). Critical assessment of such resources is essential for the practice of Quality Use of Medicines.
Learning Outcomes
On successful completion of this unit you will be able to:
- Apply knowledge of the pharmacology and the therapeutic indications of drugs endorsed for use by the Podiatry Board of Australia;
- Evaluate the appropriate selection of pharmacotherapies in your clinical practice to manage recognised interactions of medicines in patients;
- Critically analyse the design and outcome of clinical trials and associated data with respect to the efficacy and safety of drugs;
- Access resources that provide evidence for, and recommend, the appropriate selection and use of medicines; and
- Apply the principles of Quality Use of Medicines.
Content
Building a theoretical foundation for professional podiatry practice in pharmacology/pharmacotherapeutics based on the Clinical Practice Guidelines of the Podiatry Board of Australia:
The mechanisms of action, contraindications, adverse effects and interactions of the drug classes used by podiatrists in diagnosis, treatment, management and rehabilitation of podiatric conditions including:
- Antibacterial drugs
- Anti-fungal drugs
- Anti-inflammatory drugs
- Analgesic drugs
- Local anaesthetics
- Drugs to treat acute hypersensitivity reactions
- Anxiolytic drugs
Practice of evidence-based medicine:
Principles of evidenced-based medicine that provide the rationale for the appropriate selection and use of medicines in conjunction with the principles of pathology and pharmacology; design and analysis of clinical trials that measure the efficacy and safety of drugs.
Evaluate the role of the national prescribing service in guiding best practice, and setting national competency standards
The principles of the national strategy for the quality use of medicines: Implications of the national medicines policy and therapeutic goods regulation for the quality use of drugs in podiatry practice.
Skills for professional development/resources:
Use of apposite primary and secondary resources including databases and websites such as the Therapeutic Guidelines, Australian Medicines Handbook (AMH), Monthly Index of Medical Specialties (MIMS), Therapeutic Goods Administration (TGA) and the National Prescribing Service (NPS). Application of professional guidelines and other resources in clinical scenarios focussing on drug treatment and management of podiatric conditions.
Relates to learning outcomes
These learning outcomes address elements of the Podiatry Competency Standards for Australia and New Zealand from the Australian and New Zealand Podiatry Accreditation Council (ANZPAC). Students are registered with the Podiatry Board of Australia which recognises these competencies as the minimum standards for professional practice.
Please refer to Podiatry Board of Australia and ANZPAC for more information.
Learning Approaches
A flipped approach is taken in this unit and all didactic content is delivered as a recorded lecture prior to class. Tutorials contain active learning strategies such as discussing real world scenarios and solving case based pharmaceutical problems. Through interprofessional learning you will deepen your knowledge of pharmaceutical treatment options via discussion with pharmacists and learn how to use and interpret appropriate evidence and therapeutic guidelines.
Feedback on Learning and Assessment
Discussion in tutorials with peers and academics aims to provide instant feedback on learning in tutorials. Teaching in tutorials has been scaffolded to assessment as a feed forward to build the required knowledge and skills to complete the assessment.
You will be given written and verbal feedback when you receive your assessment results.
Assessment
Overview
Each assessment item is designed to measure your ability to apply the knowledge and skills stated in the unit learning outcomes. In assessment 1 you will analyse a real world case and recommend treatment options after a thorough review and critique of relevant evidence and guidelines. In the exam you will show your understanding of the content in this unit and pharmaceutical approaches.
In addition to submitting hard copies of your assessment you may be required to electronically submit all written assignments for content matching checks.
Unit Grading Scheme
7- point scale
Assessment Tasks
Assessment: Critique (Written)
Evaluation of clinical drug trials in written form. The evaluation will focus on the evidence provided for the use of drugs in the treatment of specific diseases or conditions. This is an individual assessment.
This is an assignment for the purposes of an extension.
Assessment: Examination (Written)
Answering of multiple choice and short answer questions under invigilated conditions. You will be required to solve therapeutic problems and evaluate the appropriate selection of pharmacotherapies in your clinical practice.
Academic Integrity
Academic integrity is a commitment to undertaking academic work and assessment in a manner that is ethical, fair, honest, respectful and accountable.
The Academic Integrity Policy sets out the range of conduct that can be a failure to maintain the standards of academic integrity. This includes, cheating in exams, plagiarism, self-plagiarism, collusion and contract cheating. It also includes providing fraudulent or altered documentation in support of an academic concession application, for example an assignment extension or a deferred exam.
You are encouraged to make use of QUT’s learning support services, resources and tools to assure the academic integrity of your assessment. This includes the use of text matching software that may be available to assist with self-assessing your academic integrity as part of the assessment submission process.
Breaching QUT’s Academic Integrity Policy or engaging in conduct that may defeat or compromise the purpose of assessment can lead to a finding of student misconduct (Code of Conduct – Student) and result in the imposition of penalties under the Management of Student Misconduct Policy, ranging from a grade reduction to exclusion from QUT.
Resources
The following textbooks and websites may be used in this unit.
Note: All resources are available through QUT Library.
Databases and Websites:
The following databases are accessible via QUT Library
Follow this string starting at the QUT Home page:
QUT Library -> Go to Databases Page -> Select a subject: Science & Technology -> Pharmacy -> Select the database of your choice
Resource Materials
Recommended text(s)
Australian medicines handbook. (Current Edition). Adelaide, SA: AMH Pty Ltd. Electronic version available through QUT Library Databases website or directly at www.amh.net.au
DiPiro., and et al. Pharmacotherapy: A pathophysiological approach. (Current Edition). NY: McGraw-Hill Medical Pub. Division.
Further resources are listed in the Guidelines for Endorsement for Scheduled Medicines by Podiatry Board of Australia.
Golan., and et al. Principles of pharmacology: The pathophysiological basis of drug therapy. (Current Edition). Philadelphia; Lippincott Williams & Wilkins.
MIMS. (Current Edition). Sydney, NSW: MIMS Australia and UBM Media Pty Ltd. Electronic version available through QUT Library Databases website or directly at www.mims.com.au
National Prescribing Service (NPS) at www.nps.org.au
Rang, H.P., and et al. Pharmacology. (Current Edition). Philadelphia, Pa: Churchill Livingstone Elsevier.
Therapeutic Goods Administration at www.tga.gov.au
Therapeutic Guidelines (Current Edition). Melbourne, VIC: Therapeutic Guidelines Ltd. Electronic version available through QUT Library Databases website or directly at www.tg.com.au. Essential titles for podiatry: Antibiotic, analgesic, dermatology, endocrinology, toxicology and dental.
Risk Assessment Statement
There are no out-of-the-ordinary risks associated with this unit. You will be made aware of evacuation procedures and assembly areas in the first few lectures. In the event of a fire alarm sounding, or on a lecturer's instruction, you should leave the room and assemble in the designated area, which will be indicated to you. You should be conscious of your health and safety at all times whilst on campus.